Summary:
Summary Statement of Deficiencies D0000 A Certification Survey was performed on February 7, 2019 at Trieu Dermatology, LLC, CLIA ID # 19D2120244. The laboratory was found in compliance with 42 CFR 493 Requirements for Laboratories; however, standard level deficiencies were cited. D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on observation, record review, and interview with personnel, the laboratory failed to ensure marking dyes have not exceeded their expiration dates. Findings: 1. Observation by surveyor during laboratory tour on February 7, 2019 revealed the following expired items: a) Mark IT Tissue Marking Dye, Green, Lot # 393019, Expiration Date: 11/2018, Quantity: one (1) bottle b) Mark IT Tissue Marking Dye, Orange, Lot # 393015, Expiration Date: 11/2018, Quantity: one (1) bottle c) Mark IT Tissue Marking Dye, Red, Lot # 389377, Expiration Date: 10/2018, Quantity: one (1) bottle d) Mark IT Tissue Marking Dye, Black, Lot # 394875, Expiration Date: 11 /2018, Quantity: one (1) bottle e) Mark IT Tissue Marking Dye, Blue, Lot # 389376, Expiration Date: 10/2018, Quantity: one (1) bottle 2. Review of the laboratory's "Expiration of Supplies/Chemicals" policy revealed the following: "Histotech will review supply stock periodically and dispose of expired items in accordance with established procedures." 3. In interview on February 7, 2019 at 1:15 pm, Personnel 1 stated the laboratory maintains a reagent log with expiration dates. 4. Review of the laboratory's "Reagent Receipt Log" revealed the laboratory did not include the identified items on the log. 5. In further interview on February 7, 2019, Personnel 1 stated she was unaware the identified marking dyes had an expiration date. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- D5609 HISTOPATHOLOGY CFR(s): 493.1273(e)(f) (e) The laboratory must use acceptable terminology of a recognized system of disease nomenclature in reporting results. (f) The laboratory must document all control procedures performed, as specified in this section. This STANDARD is not met as evidenced by: Based on record review and interview with personnel, the laboratory failed to ensure testing personnel documented the stain quality for Histopathology testing. Findings: 1. Review of the laboratory's CMS 209 form (Laboratory Personnel Report) revealed Personnel 1 serves as the testing personnel 2. Review of random selection of patients and quality control records revealed the laboratory did not have documented QC assessment performed by the testing personnel identified on the laboratory's CMS 209 form (Laboratory Personnel Report) for the following dates: August 31, 2017 December 12, 2017 February 7, 2018 June 11, 2018 September 5, 2018 October 10, 2018 November 27, 2018 January 15, 2019 February 6, 2019 3. In interview on February 7, 2019 at 2:00 pm, Personnel 1 stated the histotech makes a quality control slide, which she examines for stain quality. Personnel 1 stated she is not always the person documenting the acceptability, sometimes it is the histotech who performed the staining. D5781